Neurohormonal prediction of mortality following admission for decompensated heart failure

被引：33

作者：

Aronson, D

Burger, AJ

机构：

[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Noninvas Cardiol Lab, Boston, MA 02215 USA

[2] Rambam Med Ctr, Div Cardiol, Haifa, Israel

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 91卷 / 02期

关键词：

D O I：

10.1016/S0002-9149(02)03119-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Circulating concentrations of neurohormones and cytokines were measured at hospital admission in patients with decompensated heart failure. Plasma endothelin-1 levels above the group median were found to be an independent and significant predictor of death after hospital discharge.

引用

收藏

页码：245 / +

页数：5

相关论文

共 20 条

[11] Secondary pulmonary hypertension in chronic heart failure - The role of the endothelium in pathophysiology and management [J].

Moraes, DL ;

Colucci, WS ;

Givertz, MM .

CIRCULATION, 2000, 102 (14) :1718-1723

[12] PLASMA ENDOTHELIN DETERMINATION AS A PROGNOSTIC INDICATOR OF 1-YEAR MORTALITY AFTER ACUTE MYOCARDIAL-INFARCTION [J].

OMLAND, T ;

LIE, RT ;

AAKVAAG, A ;

AARSLAND, T ;

DICKSTEIN, K .

CIRCULATION, 1994, 89 (04) :1573-1579

[13] Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure [J].

Pacher, R ;

Stanek, B ;

Hulsmann, M ;

KollerStrametz, J ;

Berger, R ;

Schuller, M ;

Hartter, E ;

Ogris, E ;

Frey, B ;

Heinz, G ;

Maurer, G .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (03) :633-641

[14]

Pousset F, 1997, EUR HEART J, V18, P254

[15] Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction [J].

Richards, AM ;

Doughty, R ;

Nicholls, MG ;

Macmahon, S ;

Ikram, H ;

Sharpe, N ;

Espiner, EA ;

Frampton, C ;

Yandle, TG .

CIRCULATION, 1999, 99 (06) :786-792

[16] Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure [J].

Selvais, PL ;

Robert, A ;

Ahn, S ;

Van Linden, F ;

Ketelslegers, JM ;

Pouleur, H ;

Rousseau, MF .

JOURNAL OF CARDIAC FAILURE, 2000, 6 (03) :201-207

[17] Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction [J].

Stanek, B ;

Frey, B ;

Hülsmann, M ;

Berger, R ;

Sturm, B ;

Strametz-Juranek, J ;

Bergler-Klein, J ;

Moser, P ;

Bojic, A ;

Hartter, E ;

Pacher, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) :436-442

[18] Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD) [J].

TorreAmione, G ;

Kapadia, S ;

Benedict, C ;

Oral, H ;

Young, JB ;

Mann, DL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (05) :1201-1206

[19] Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations [J].

Troughton, RW ;

Frampton, CM ;

Yandle, TG ;

Espiner, EA ;

Nicholls, MG ;

Richards, AM .

LANCET, 2000, 355 (9210) :1126-1130

[20] ENDOTHELIN IN HUMAN CONGESTIVE-HEART-FAILURE [J].

WEI, CM ;

LERMAN, A ;

RODEHEFFER, RJ ;

MCGREGOR, CGA ;

BRANDT, RR ;

WRIGHT, S ;

KAO, PC ;

EDWARDS, WD ;

BURNETT, JC ;

HEUBLEIN, DM .

CIRCULATION, 1994, 89 (04) :1580-1586